High-Risk Localized and Locally Advanced Prostate Cancer

• Andere auteurs: Izumi, Kouji (Redacteur)
• Formaat: Elektronisch Hoofdstuk
• Taal: Engels
• Gepubliceerd in: Basel MDPI - Multidisciplinary Digital Publishing Institute 2023
• Onderwerpen: Technology: general issues; Biotechnology; imaging modality;   oligometastasis; radical prostatectomy; lymph node dissection; brachytherapy; hormonal therapy; neoadjuvant/adjuvant therapy; quality of life; local invasion
• Online toegang: DOAB: download the publication; DOAB: description of the publication

Around 20%-30% of nonmetastatic prostate cancer patients have high-risk localized disease. The best treatment for high-risk localized disease is still unclear, and the reliability of the definition of "high-risk" may need to be validated first. Although recent advances in radiotherapy for...